Basic Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. Mar 15, 2004; 10(6): 860-863
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.860
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Morphologic changes of MiaPaCa-2 cells treated by daidzein. A: Control, B: Cells treated by 10 μmol/L of daidzein for 3 d, C: Cells treated by 75 μmol/L of daidzein for 3 d (×200).
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Morphologic changes of PANC-1 cells treated by daidzein. A: Control, B: Cells treated by 10 μmol/L of daidzein for 3 d, C: Cells treated by 75 μmol/L of daidzein for 3 d (×200).
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Inhibitory effects of daidzein on growth of estrogen-receptor-positive pancreatic cancer MiaPaCa-2 cells. 0.1 μmol/L, 1 μmol/L, 10 μmol/L, 25 μmol/L, 50 μmol/L, 75 μmol/L and 100 μmol/L of daidzein were used, respectively.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Inhibitory effects of daidzein on growth of estrogen-receptor-negative pancreatic cancer PANC-1 cells. 0.1 μmol/L, 1 μmol/L, 10 μmol/L, 25 μmol/L, 50 μmol/L, 75 μmol/L and 100 μmol/L of daidzein were used, respectively.